HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenya Yoshida Selected Research

hepatoma-derived growth factor

2/2006Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma.
1/2006Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma.
6/2004Hepatoma-derived growth factor is a neurotrophic factor harbored in the nucleus.
3/2004Circulating auto-antibody against hepatoma-derived growth factor (HDGF) in patients with ulcerative colitis.
12/2003Hepatoma-derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor.
11/2003Expression of hepatoma-derived growth factor in hepatocarcinogenesis.
12/2002Hepatoma-derived growth factor is highly expressed in developing liver and promotes fetal hepatocyte proliferation.
11/2002Antibodies against hepatoma-derived growth factor and mucosal repair in ulcerative colitis.
11/2002Antisense oligonucleotides of hepatoma-derived growth factor (HDGF) suppress the proliferation of hepatoma cells.
11/2002Participation of hepatoma-derived growth factor in the regulation of fetal hepatocyte proliferation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenya Yoshida Research Topics

Disease

6Hepatocellular Carcinoma (Hepatoma)
02/2006 - 11/2002
5Neoplasms (Cancer)
08/2011 - 11/2002
4Chronic Hepatitis C
05/2007 - 09/2002
2Lung Neoplasms (Lung Cancer)
02/2013 - 08/2011
2Colitis
03/2004 - 11/2002
2Ulcerative Colitis
03/2004 - 11/2002
1Polyploidy
12/2012
1Stomach Neoplasms (Stomach Cancer)
08/2011
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2010
1Pleural Effusion (Pleural Effusions)
07/2009
1Pulmonary Plasma Cell Granuloma
11/2008
1Autoimmune Pancreatitis
11/2008
1Lymphatic Metastasis
01/2006
1Carcinoma (Carcinomatosis)
01/2006
1Cholestasis
10/2005
1Proctitis
03/2004
1Carcinogenesis
12/2003
1Hepatitis
11/2003
1Fatty Liver
11/2003
1Virus Diseases (Viral Diseases)
09/2002

Drug/Important Bio-Agent (IBA)

10hepatoma-derived growth factorIBA
02/2006 - 11/2002
4RNA (Ribonucleic Acid)IBA
05/2007 - 09/2002
4InterferonsIBA
05/2007 - 09/2002
3Amantadine (Aman)FDA LinkGeneric
05/2007 - 01/2003
3Conditioned Culture MediaIBA
06/2004 - 11/2002
2Proteins (Proteins, Gene)FDA Link
02/2013 - 11/2002
2Immunoglobulin G (IgG)IBA
11/2008 - 03/2004
2AntibodiesIBA
03/2004 - 11/2002
1Cyclin EIBA
12/2012
1Cyclin BIBA
12/2012
1CyclinsIBA
08/2011
1Epithelial Cell Adhesion MoleculeIBA
08/2011
1VimentinIBA
10/2010
1Cadherins (E-Cadherin)IBA
10/2010
1Ribavirin (Virazole)FDA LinkGeneric
05/2007
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2006
1Heparin (Liquaemin)FDA LinkGeneric
06/2004
1EnzymesIBA
03/2004
1Dihydrotachysterol (AT 10)IBA
03/2004
1ImmunosorbentsIBA
03/2004
1Neutralizing AntibodiesIBA
12/2003
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2003
1Choline (Choline Chloride)IBA
11/2003
1Amino AcidsFDA Link
11/2003
1human AZU1 proteinIBA
12/2002
1AutoantibodiesIBA
11/2002
1Antisense OligonucleotidesIBA
11/2002
1Liposomes (Liposome)IBA
11/2002

Therapy/Procedure

4Therapeutics
08/2011 - 01/2003
1X-Ray Film
07/2009
1Retreatment
05/2007
1Stents
10/2005